Instylla, Inc., a Bedford, Mass.-based company developing minimally invasive liquid embolic products designed for use in peripheral vascular embolotherapy, closed a $25.4 millionSeries B financing. Backers included new investors Excelestar Ventures, Catalyst Health Ventures, and Amed Ventures. Existing investors Ascension Ventures, Sparta Group and Incept also participated. As part of the financingTasneem DohadwalaandDarshana Zaveriwill join The post Instylla Closes $25.4M Series B Financing appeared first on Independent Newspapers Nigeria. Click here to read full news..